CIK: 0001351351 · Show all filings
Period: Q2 2019 (← Previous) (Next →)
Filing Date: Aug 14, 2019
Total Value ($000): $276,436 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | RED HAT INC | 447,175 | $83,962 | 30.4% | $184.87 | — | COM | 756577102 |
| — | ANADARKO PETE CORP | 898,900 | $63,426 | 22.9% | $70.56 | — | COM | 032511107 |
| — | SPARK THERAPEUTICS INC | 320,653 | $32,828 | 11.9% | $104.71 | — | COM | 84652J103 |
| — | CELGENE CORP | 322,721 | $29,832 | 10.8% | $93.85 | — | COM | 151020104 |
| — | ZAYO GROUP HLDGS INC | 622,559 | $20,488 | 7.4% | $32.91 | — | COM | 98919V105 |
| — | MELLANOX TECHNOLOGIES LTD | 173,776 | $19,232 | 7.0% | $118.36 | — | SHS | M51363113 |
| CVS | CVS HEALTH CORP | 222,309 | $12,114 | 4.4% | $59.39 | -26.6% | COM | 126650100 |
| CVS | CVS HEALTH CORP | 135,400 | $7,378 | 2.7% | $59.39 | -26.6% | Call | 126650100 |
| — | ALLERGAN PLC | 25,000 | $4,186 | 1.5% | $167.44 | — | SHS | G0177J108 |
| — | GENESEE & WYO INC | 15,000 | $1,500 | 0.5% | $100.00 | — | CL A | 371559105 |
| — | ALTISOURCE ASSET MGMT CORP | 69,122 | $795 | 0.3% | $68.33 | — | COM | 02153X108 |
| — | ARRAY BIOPHARMA INC | 15,000 | $695 | 0.3% | $46.33 | — | COM | 04269X105 |